|Title:|| Process of preparing enantiomers of carbazole derivatives|
|Abstract:|| A (+) or (-) enantiomer of a compound of formula (I) wherein R.sup.4 is methyl or ethyl, or a salt, solvate or hydrate thereof, processes for preparing said compounds and pharmaceutical compositions containing them. Compounds of formula (+) are 5-HT.sub.1 -like agonists.|
|Inventor(s):|| Borrett; Gary T. (Stansted, GB2), Kitteringham; John (Hertford, GB2), Porter; Roderick A. (Ashwell, GB2), Shipton; Mark R. (Bishop's Stortford, GB2), Vimal; Mythily (Edmonton, GB2), Young; Rodney C. (Oxford, GB2) |
|Assignee:|| SmithKline Beecham, p.l.c. (GB2) |
1. A process for preparing (+)-6-carboxamido-3-methylamino-1,2,3,4-tetrahydrocarbazole or a salt, solvate or hydrate thereof which comprises:
(a) Separation of an enantiomeric mixture of (.+-.)-6-carboxamido-3-methylamino-1,2,3,4-tetrahydrocarbazole or a derivative thereof by chromatography, wherein said enantiomeric mixture is prepared by reaction of 4-carboxamido-phenylhydrazine, or
a salt thereof, with a ketal of formula (II): ##STR7## wherein R.sup.1 is methyl, R.sup.2 is hydrogen or an N-protecting group and A is an alkylene moiety, said compound of formula (II) being prepared from a protected 1,4-cyclohexane-dione of formula
(III): ##STR8## by reaction with an appropriate alkylamine compound.
2. A process according to claim 1 wherein the reaction between a compound of formula (II) and an alkylamine is effected in the presence of suitable molecular sieves to give the corresponding iminoketal derivative which is then converted to an
alkylamino compound of formula (II) by catalytic hydrogenation.
3. A process according to claim 2 wherein reaction of a compound of formula (III) with an alkylamine is effected in a hydrocarbon solvent.
4. A process according to claim 3 wherein ethanol is added to the reaction mixture prior to catalytic hydrogenation.
5. A process according to claim 1 wherein reaction between a compound of formula (III) and an alkylamine is effected in ethanol and the mixture hydrogenated directly to give a compound of formula (II), followed if necessary or desired by removal
of any N-protecting group, and conversion of a salt into a free base and/or salt formation.